HMA/EMA Big Data Stakeholder Forum 2023

When: 04/12/2023 - 04/12/2023
Where: Amsterdam, The Netherlands
As the journey towards data-driven medicines regulation accelerates, the fourth annual Big Data multi-stakeholder forum will take place on 4 December 2023 at the EMA building in Amsterdam

Understanding when to have confidence in novel technologies and the evidence generated from Big Data will benefit public health by supporting medicines development, improving treatment outcomes and facilitating earlier patient access to innovative treatments.

As the journey towards data-driven medicines regulation accelerates, the fourth annual Big Data multi- stakeholder forum will take place on 4 December 2023 at the EMA building in Amsterdam (+ enabled virtual participation). It aims to:

  • inspire with opportunities for the future thanks to keynotes speakers;
  • discuss with stakeholders data-enabled opportunities to improve medicines development and the EU;
  • inform and strengthen collaboration with stakeholders and partners on the delivery of the data activities included the Network Strategy to 2025 (fourth update of the HMA-EMA Big Data Steering Group workplan).

More info and registration HERE

Tag: | Events: 333 of 362
All events

News

  • 02/05/2024

    Unveiling the Future: Highlights from the FDA/MDIC Symposium on Computational Modeling and Simulation (CM&S) in Washington D.C.

    • The FDA/MDIC Symposium on Computational Modeling and Simulation (CM&S) in Washington DC (April 15-17, 2024) unfolded its vibrant tapestry for three enlightening days of interdisciplinary innovation and collaboration. -Read more-
  • 30/04/2024

    Council releases Draft Conclusions on Horizon 2020 evaluation

    • The Council of the European Union highlighted the significance of Horizon 2020 in bolstering the EU's competitiveness in its Draft Conclusions regarding the ex-post evaluation of the research and innovation funding program. -Read more-
  • 30/04/2024

    WHO introduces cutting-edge digital health advocate utilizing generative AI for public health

    • The World Health Organization (WHO) announces the debut of S.A.R.A.H., a prototype digital health advocate equipped with an enhanced empathetic interface driven by generative artificial intelligence (AI). -Read more-
  • 30/04/2024

    EFPIA advocates for responsible AI use in medicine development

    • The European Federation of Pharmaceutical Industries and Associations (EFPIA) underlines the potential benefits of employing Artificial Intelligence (AI) in advancing patient care, fostering innovation, and benefiting society at large. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO